Mold Toxicity Testing on Salt Spring Island

Mold toxicity testing measures mycotoxins (toxic compounds produced by mold species like Aspergillus, Stachybotrys, and Penicillium) that accumulate in the body after exposure. Mycotoxin illness is increasingly recognized as a root cause of complex, multi-system symptoms that resist conventional treatment.

Mold exposure is far more common than most people realize. Water-damaged buildings, which include up to 50% of North American structures according to research published in the journal Indoor Air, are the primary source. Mycotoxins are small enough to become airborne, be inhaled, and enter the bloodstream, where they can disrupt immune function, trigger chronic inflammation, and impair neurological and hormonal health. Patients with certain genetic predispositions (HLA-DR gene variants) are particularly vulnerable because their immune systems struggle to clear these toxins.

I use a urine mycotoxin panel that tests for a broad range of mycotoxins including ochratoxin A, aflatoxins, gliotoxin, and trichothecenes. This testing reveals whether your body is carrying a significant mycotoxin burden, information that standard blood tests and conventional workups simply don't capture. Research in the journal Toxins demonstrates that urinary mycotoxin testing is a clinically useful tool for identifying patients with mold-related illness.

When mycotoxin burden is confirmed, treatment focuses on binding and removing toxins (using agents like cholestyramine, activated charcoal, and clay binders), supporting detoxification pathways with targeted supplementation, reducing inflammation, and restoring immune function. Equally important is identifying and remediating the source of exposure. I work with you on all fronts to build a comprehensive recovery plan.